ICAM1 and breast cancer: Specifically, it correlated the levels of four circulating inflammatory biomarkers (high-sensitivity C-reactive protein, fibrinogen, N-acetyl side-chains of acute phase proteins, and soluble intercellular adhesion molecule-1) with breast cancer risk.